Fractyl Health Statistics
Total Valuation
Fractyl Health has a market cap or net worth of $111.18 million. The enterprise value is $130.49 million.
Important Dates
The last earnings date was Tuesday, May 13, 2025, after market close.
| Earnings Date | May 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Fractyl Health has 48.98 million shares outstanding. The number of shares has increased by 436.83% in one year.
| Current Share Class | 48.98M |
| Shares Outstanding | 48.98M |
| Shares Change (YoY) | +436.83% |
| Shares Change (QoQ) | +0.87% |
| Owned by Insiders (%) | 3.72% |
| Owned by Institutions (%) | 25.20% |
| Float | 18.16M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1,852.95 |
| Forward PS | n/a |
| PB Ratio | 17.42 |
| P/TBV Ratio | 17.44 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2,174.90 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.50, with a Debt / Equity ratio of 9.64.
| Current Ratio | 2.50 |
| Quick Ratio | 2.24 |
| Debt / Equity | 9.64 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -196.81% and return on invested capital (ROIC) is -56.91%.
| Return on Equity (ROE) | -196.81% |
| Return on Assets (ROA) | -49.05% |
| Return on Invested Capital (ROIC) | -56.91% |
| Return on Capital Employed (ROCE) | -150.61% |
| Revenue Per Employee | $561 |
| Profits Per Employee | -$832,776 |
| Employee Count | 107 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -65.08% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -65.08% |
| 50-Day Moving Average | 1.56 |
| 200-Day Moving Average | 2.00 |
| Relative Strength Index (RSI) | 58.63 |
| Average Volume (20 Days) | 385,777 |
Short Selling Information
The latest short interest is 2.74 million, so 5.59% of the outstanding shares have been sold short.
| Short Interest | 2.74M |
| Short Previous Month | 2.86M |
| Short % of Shares Out | 5.59% |
| Short % of Float | 15.07% |
| Short Ratio (days to cover) | 10.94 |
Income Statement
In the last 12 months, Fractyl Health had revenue of $60,000 and -$89.11 million in losses. Loss per share was -$1.84.
| Revenue | 60,000 |
| Gross Profit | 29,000 |
| Operating Income | -96.75M |
| Pretax Income | n/a |
| Net Income | -89.11M |
| EBITDA | -95.83M |
| EBIT | -96.75M |
| Loss Per Share | -$1.84 |
Full Income StatementBalance Sheet
The company has $42.11 million in cash and $61.43 million in debt, giving a net cash position of -$19.32 million or -$0.39 per share.
| Cash & Cash Equivalents | 42.11M |
| Total Debt | 61.43M |
| Net Cash | -19.32M |
| Net Cash Per Share | -$0.39 |
| Equity (Book Value) | 6.38M |
| Book Value Per Share | 0.13 |
| Working Capital | 28.24M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$78.89 million and capital expenditures -$1.15 million, giving a free cash flow of -$80.04 million.
| Operating Cash Flow | -78.89M |
| Capital Expenditures | -1.15M |
| Free Cash Flow | -80.04M |
| FCF Per Share | -$1.63 |
Full Cash Flow StatementMargins
| Gross Margin | 48.33% |
| Operating Margin | -161,246.67% |
| Pretax Margin | -148,511.67% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Fractyl Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -436.83% |
| Shareholder Yield | -436.83% |
| Earnings Yield | -80.15% |
| FCF Yield | -72.00% |
Analyst Forecast
The average price target for Fractyl Health is $10.00, which is 340.53% higher than the current price. The consensus rating is "Buy".
| Price Target | $10.00 |
| Price Target Difference | 340.53% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 306.42% |
| EPS Growth Forecast (5Y) | -24.08% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Fractyl Health has an Altman Z-Score of -9.55 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -9.55 |
| Piotroski F-Score | 2 |